Literature DB >> 11379329

Relationship between the fecal occult blood test and benign anal disorders.

K Sasaki1, M Kunimoto, K Hirata.   

Abstract

BACKGROUND/AIMS: The fecal occult blood test is a very useful method for mass screening for colorectal cancer. The possibility of the fecal occult blood test being positive is high even in benign anal disorders, but the relationship between anal disorders and the fecal occult blood test has not been fully studied.
METHODOLOGY: During the period from November 1995 to April 1996, we performed both fecal occult blood test and sigmoid colonofiberscopy for 440 patients with anal disorders who visited our hospital for the first time.
RESULTS: The positive fecal occult blood test rate was 18.8% (77/409) for those who had only anal disorders and no findings in the colon and rectum. The positive fecal occult blood test rate was significantly high in the cases with polyps (42.3%) and in those with colorectal cancer (60%).
CONCLUSIONS: These findings suggested the need to analyze fecal occult blood test, keeping in mind that fecal occult blood test might be positive even without any malignant findings in the large intestine in about 20% of cases of patients have anal disorders when fecal occult blood test is performed.

Entities:  

Mesh:

Year:  2001        PMID: 11379329

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis.

Authors:  Ulrike Haug; Amy B Knudsen; Karen M Kuntz
Journal:  Int J Cancer       Date:  2012-03-29       Impact factor: 7.396

2.  Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing.

Authors:  Miriam P van der Meulen; Esther Toes-Zoutendijk; Manon C W Spaander; Evelien Dekker; Johannes M G Bonfrer; Anneke J van Vuuren; Ernst J Kuipers; Folkert J van Kemenade; M F van Velthuysen; Maarten G J Thomeer; Harriët van Veldhuizen; Harry J de Koning; Iris Lansdorp-Vogelaar; Monique E van Leerdam
Journal:  PLoS One       Date:  2022-02-17       Impact factor: 3.240

3.  Adenocarcinoma within anorectal fistulae: different clinicopathological characteristics between Crohn's disease-associated type and the usual type.

Authors:  Makoto Kodama; Daisuke Kobayashi; Kuniko Iihara; Keiko Abe; Rikisaburo Sahara; Motoki Sassa; Tetsuo Yamana; Satomi Furukawa; Takashi Yao; Keisuke Uchida; Tomoki Tamura; Mariko Negi; Yoshinobu Eishi
Journal:  Mod Pathol       Date:  2018-09-11       Impact factor: 7.842

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.